Kringle Pharma (4884) · RiskWorsened
Risk of disputes over third-party intellectual property rights
First written in FY2020. 1 of 2 entries say "Worsened", first in FY2022. Latest entry: FY2022.
2entries
3years
0from disclosures
How it moved
Same theme, other companies
Risk of Infringing Third-Party Intellectual Property RightsA theme 465 companies write about · 468 as a headwind · 1 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 469 threads.Full recordFilings, disclosures and news, newest first
- FY2022WorsenedAnnual report
「今後、事業の進捗により、このようなリスクは増大するものと思われます。」
事業進捗に伴って第三者知的財産権に関するリスクが増大するとの見通しを明示している。 - FY2020First statedAnnual report
「We conduct ongoing research, review and assessment to avoid infringing third-party intellectual property rights, but disputes relating to third-party intellectual property rights may nevertheless arise.」
Although the company conducts research, review and assessment, it acknowledges that disputes involving third-party intellectual property rights cannot be completely avoided.